Monocyte or white blood cell counts and β(2) microglobulin predict the durable efficacy of daratumumab with lenalidomide
单核细胞或白细胞计数以及β2微球蛋白水平可预测达雷妥尤单抗联合来那度胺治疗的持久疗效。
期刊:Therapeutic Advances in Hematology
影响因子:3.1
doi:10.1177/20406207221142487
Shimazu, Yutaka; Kanda, Junya; Kaneko, Hitomi; Imada, Kazunori; Yamamura, Ryosuke; Kosugi, Satoru; Shimura, Yuji; Ito, Tomoki; Fuchida, Shin-Ichi; Uchiyama, Hitoji; Fukushima, Kentaro; Yoshihara, Satoshi; Hanamoto, Hitoshi; Tanaka, Hirokazu; Uoshima, Nobuhiko; Ohta, Kensuke; Yagi, Hideo; Shibayama, Hirohiko; Onda, Yoshiyuki; Tanaka, Yasuhiro; Adachi, Yoko; Matsuda, Mitsuhiro; Iida, Masato; Miyoshi, Takashi; Matsui, Toshimitsu; Takahashi, Ryoichi; Takakuwa, Teruhito; Hino, Masayuki; Hosen, Naoki; Nomura, Shosaku; Shimazaki, Chihiro; Matsumura, Itaru; Takaori-Kondo, Akifumi; Kuroda, Junya
